Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Commentary, J Sleep Disor Treat Care Vol: 2 Issue: 3
Sodium Oxibate and Breathing
| Ortega-Albás JJ1* and Ortega Gabás SP2 |
| 1Sleep Unit Universitary, General Hospital of Castellón Castellón de la Plana, Spain |
| 2Polytechnic University of Valencia, Valencia, Spain |
| Corresponding author :Ortega-Albás JJ Sleep Unit, Universitary General Hospital of Castellón, Castellón de la Plana, Avenida Capuchinos 41, 2° D. 12004. Castellón, Spain Tel: 638713784 E-mail: jjoral@ono.com |
| Received: April 09, 2013 Accepted: August 08, 2013 Published: August 10, 2013 |
| Citation: Ortega-Albás JJ, Ortega Gabás SP (2013) Sodium Oxibate and Breathing. J Sleep Disor: Treat Care 2:3. doi:10.4172/2325-9639.1000116 |
Abstract
Sodium Oxibate and Breathing
The gamma-hydroxybutyrate acid (GHB) is a short chain fatty acid, an endogenous metabolite of gamma–aminobutyric acid (GABA), known major inhibitor neurotransmitter. The GHB presents an action fundamentally at Central Nervous System (CNS) level, and possesses a high affinity for specific receptors located in the cerebral cortex and in the medulla. Sodium Oxybate (SO) is the sodium salt of the GHB. Its character as inhibitor neuromodulator, with the possibility of inducing respiratory depression, and the potential risk of abuse/misuse forces clinicians to be constantly monitoring for signs of misuse.
